Alternating hemiplegia of childhood

Piriyankan Ananthavarathan1, Salwa Kamourieh1

  • 1Department of Neurology, Headache and Facial Pain Group, National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom.

PubMed

Insights

Alternating hemiplegia of childhood (AHC) is a severe neurodevelopmental disorder. Mutations in the ATP1A3 gene are implicated, and flunarizine is the preferred treatment for preventing attacks.

Area of Science:

  • Pediatric Neurology
  • Neurogenetics
  • Rare Diseases

Background:

  • Alternating hemiplegia of childhood (AHC) presents with recurrent hemiplegic episodes and severe neurodevelopmental impairments.
  • Associated symptoms include dystonia, nystagmus, dysautonomia, developmental delay, and epilepsy.
  • Diagnosis relies on clinical history and Aicardi criteria.

Conclusions:

  • AHC is a complex neurodevelopmental disorder with a genetic basis in ATP1A3.
  • Effective management involves symptomatic treatment, trigger avoidance, and specific pharmacotherapies like flunarizine.